Uveitis associated with topical β-blockers

Archives of Ophthalmology

Volumn 114, Issue 10, 1996, Pages 1181-1182

  Beck, Roy W ^a,b,d   Moke, Pamela ^a,b,d   Blair, R Clifford ^a,b   Nissenbaum, Richard ^c,e  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Humana Health Care Plan of Tampa Bay   (United States)

^d Jaeb Center   (United States)

^e Humana Health Care Plan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METIPRANOLOL;

ADULT; ARTICLE; DATA BASE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; FEMALE; GRANULOMATOUS INFLAMMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; UVEITIS;

EID: 0029848937     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140381002     Document Type: Article

References (6)

1. Zimmerman TJ, Baumann JD, Hetherington J. Side effects of timolol. Sun Ophthalmol. 1983;28:243-249.
2. Jain S. Betaxolol-associated anterior uveitis. Eye. 1994;8:708-709.
3. Melles RB. Metipranolol-associated granulomatous iritis. Am J Ophthalmol. 1994; 118:712-715.
4. Schulz JS, Hoenig JA, Charles H. Possible bilateral anterior uveitis secondary to metipranolol (OptiPranolol) therapy. Arch Ophthalmol. 1993;111:1606-1607.
5. Akingbehin T, Villada JR. Metipranalol-associated granulomatous anterior uveitis. Br J Ophthalmol. 1991;75:519-523.
6. Betagan (levobunolol HCI) ophthalmic solution [package insert]. Irvine, Calif: Allergan Inc; 1996.